Vertex Pharmaceuticals Inc (VRTX) — Capital Reinvestment Ratio
Vertex Pharmaceuticals Inc (VRTX) has a Capital Reinvestment Ratio of 0.09x as of March 2026, meaning it reinvests 0% of its operating cash flow ($1.43 Billion) in capital expenditures ($133.40 Million). See Vertex Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vertex Pharmaceuticals Inc Capital Reinvestment Ratio (1993–2025)
This chart tracks Vertex Pharmaceuticals Inc's Capital Reinvestment Ratio across 12 annual periods. Check how aggressively does Vertex Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Vertex Pharmaceuticals Inc (1993–2025)
Year-by-year Capital Reinvestment Ratio for Vertex Pharmaceuticals Inc from 1993 to 2025. For live market cap and broader valuation context, see VRTX market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $3.63 Billion | $437.60 Million | ▲ +65.0% |
| 2023 | 0.07x | $3.54 Billion | $258.40 Million | ▲ +47.4% |
| 2022 | 0.05x | $4.13 Billion | $204.70 Million | ▼ -44.2% |
| 2021 | 0.09x | $2.64 Billion | $235.00 Million | ▲ +11.3% |
| 2020 | 0.08x | $3.25 Billion | $259.80 Million | ▲ +66.1% |
| 2019 | 0.05x | $1.57 Billion | $75.45 Million | ▼ -36.1% |
| 2018 | 0.08x | $1.27 Billion | $95.52 Million | ▼ -75.5% |
| 2017 | 0.31x | $844.94 Million | $259.42 Million | ▲ +28.2% |
| 2016 | 0.24x | $236.10 Million | $56.56 Million | ▼ -9.8% |
| 2012 | 0.27x | $267.84 Million | $71.14 Million | ▼ -59.6% |
| 2011 | 0.66x | $143.74 Million | $94.59 Million | ▲ +214.4% |
| 1993 | 0.21x | $8.60 Million | $1.80 Million | — |